Genentech, the US biotech arm of Swiss pharma giant Roche, is building a new small-batch biologics manufacturing facility at its Oceanside campus in California, USA...
Bowing to growing pressure from activist investors with different missions, the supervisory board of tradition-steeped German pharmaceuticals and agrochemicals player...
02.12.2018
- Genentech, part of Swiss drugs giant Roche, has agreed to buy Jecure Therapeutics, a US biotech focused on discovering novel treatments for non-alcoholic steatohepatitis (NASH) and...
29.10.2018
- The US Food and Drug Administration (FDA) has approved a new drug produced by Genentech to treat acute uncomplicated influenza (flu) in patients 12 years of age and older who have...
04.09.2018
- German biopharma Affimed has agreed a strategic collaboration with Genentech, part of Swiss drug giant Roche, to develop immunotherapies for multiple cancers. Affimed will apply...
24.11.2017
- In a suit filed in the state of Delaware, the Swiss-based Roche Holding is suing Pfizer to block the future marketing a biosimilar of its breast-cancer drug Herceptin in the US...
16.06.2017
- US biotechnology group Genentech, part of Roche, is handing back rights to NewLink Genetics’ IDO inhibitor GDC-0919 (navoximod), an investigational cancer treatment. Genentech...
12.01.2017
- More than 350 companies headquartered or with operations in the US, including such diverse enterprises as Monsanto, Genentech, Unilever, L’Oreal USA and the Merck Family Fund...
